Citations

Showing 10 of 108119 citations.

Weaning from antiseizure drugs after new onset status epilepticus
Chakraborty, Tia , Hocker, Sara E. , Hocker, Sara

Mayo Clinic

Epilepsia | April 9, 2019 | Volume: 60 | Issue: 5 | Pages: 979-985

10.1111/epi.14730 | PMID 30963565 Get It

SummaryObjectiveIn patients with status epilepticus (SE) without prior epilepsy, there are limited data on the safety of discontinuing antiseizure drugs (ASDs) after seizure control. We aimed to describe seizure recurrence when weaning from ASDs following new onset SE (NOSE).MethodsRetrospective review of adult patients with NOSE admitted to Mayo Clinic, Rochester, Minnesota between January 1, 1990 and December 31, 2015 was performed. Weaning was defined as a discontinuation of ASDs following discharge. Patient demographics, SE characteristics, timing of ASD withdrawal, and seizure recurrence were collected.ResultsOne hundred seventy‐seven patients with mean age 63 ± 18 years were identified; 96 (54.2%) patients had refractory SE (RSE), and 81 (45.8%) had nonrefractory SE. Mean follow‐up was 3.8 ± 3.2 years for those successfully weaned off ASDs. One hundred thirty (73.4%) with outpatient follow‐up were included in the analysis; 128 (98.5%) patients were discharged on an ASD; 44 of 128 (34.4%) patients underwent weaning from at least 1 ASD following discharge, including 27 of 128 (21.1%) who were completely weaned off of all ASDs. Younger patients (P = 0.009) and those with RSE (P = 0.048, odds ratio = 2.12, 95% confidence interval = 1.00‐4.48) tended to undergo weaning. Six of 44 (13.6%) patients had seizure recurrence when weaned off of any ASD, and two of 27 (7.4%) patients completely weaned off all ASDs had seizure recurrence. Two of seven (28.6%) patients who underwent attempted barbiturate weaning experienced seizure recurrence.SignificanceWe found a rate of 13.6% for late seizure recurrence after weaning from at least one ASD in patients with NOSE; seizure recurrence was more likely in patients with RSE treated with barbiturates. Systematic collection of longitudinal data in patients requiring multiple ASDs for NOSE control will provide more conclusive guidance on weaning from ASDs.
Plasma Metabolites Associated with Brain MRI Measures of Neurodegeneration in Older Adults in the Atherosclerosis Risk in Communities–Neurocognitive Study (ARIC-NCS)
Li, Danni , Jack, Clifford R. , Mielke, Michelle M. , Mosley, Tom, Alonso, Álvaro , Jack, Clifford R , Mielke, Michelle M , Alonso, Alvaro , Misialek, Jeffrey R. , Knopman, David S. , Gottesman, Rebecca F.

Mayo Clinic

International Journal of Molecular Sciences | April 9, 2019 | Volume: 20 | Issue: 7 | Pages: 1744

10.3390/ijms20071744 | PMID 30970556 Get It

Background: Plasma metabolites are associated with cognitive and physical function in the elderly. Because cerebral small vessel disease (SVD) and neurodegeneration are common causes of cognitive and physical function decline, the primary objective of this study was to investigate the associations of six plasma metabolites (two plasma phosphatidylcholines [PCs]: PC aa C36:5 and PC aa 36:6 and four sphingomyelins [SMs]: SM C26:0, SM [OH] C22:1, SM [OH] C22:2, SM [OH] C24:1) with magnetic resonance imaging (MRI) features of cerebral SVD and neurodegeneration in older adults. Methods: This study included 238 older adults in the Atherosclerosis Risk in Communities study at the fifth exam. Multiple linear regression was used to assess the association of each metabolite (log-transformed) in separate models with MRI measures except lacunar infarcts, for which binary logistic regression was used. Results: Higher concentrations of plasma PC aa C36:5 had adverse associations with MRI features of cerebral SVD (odds ratio of 1.69 [95% confidence interval: 1.01, 2.83] with lacunar infarct, and beta of 0.16 log [cm3] [0.02, 0.30] with log [White Matter Hyperintensities (WMH) volume]) while higher concentrations of 3 plasma SM (OH)s were associated with higher total brain volume (beta of 12.0 cm3 [5.5, 18.6], 11.8 cm3 [5.0, 18.6], and 7.3 cm3 [1.2, 13.5] for SM [OH] C22:1, SM [OH] C22:2, and SM [OH] C24:1, respectively). Conclusions: This study identified associations between certain plasma metabolites and brain MRI measures of SVD and neurodegeneration in older adults, particularly higher SM (OH) concentrations with higher total brain volume.
Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics
Ostrom, Quinn T. , Egan, Kathleen M. , Gerke, Travis , Thompson, Reid C., LaRocca, Renato V., Chowdhary, Sajeel, Eckel‐Passow, Jeanette E. , Armstrong, Georgina , Bernstein, Jonine L. , Claus, Elizabeth B. , Johansen, Christoffer , Lai, Rose , Merrell, Ryan , Sadetzki, Siegal , Schildkraut, Joellen M. , Shete, Sanjay , Houlston, Richard S. , Jenkins, Robert B. , Wrensch, Margaret , Melin, Beatrice , Barnholtz‐Sloan, Jill S. , Bondy, Melissa L. , Houlston, Richard S , Barnholtz-Sloan, Jill S , Nabors, Burt , Olson, Jeffrey J. , Armstrong, Georgina , Wiencke, John K. , Il’yasova, Dora , Lachance, Daniel Honore , Olson, Sara H. , Amos, Christopher I. , Huse, Jason T. , Ostrom, Quinn T

Mayo Clinic

International Journal of Cancer | April 9, 2019 | Volume: 146 | Issue: 3 | Pages: 739-748

10.1002/ijc.32318 | PMID 30963577 Get It

Glioma incidence is highest in non‐Hispanic Whites, and to date, glioma genome‐wide association studies (GWAS) to date have only included European ancestry (EA) populations. African Americans and Hispanics in the US have varying proportions of EA, African (AA) and Native American ancestries (NAA). It is unknown if identified GWAS loci or increased EA is associated with increased glioma risk. We assessed whether EA was associated with glioma in African Americans and Hispanics. Data were obtained for 832 cases and 675 controls from the Glioma International Case–Control Study and GliomaSE Case–Control Study previously estimated to have <80% EA, or self‐identify as non‐White. We estimated global and local ancestry using fastStructure and RFMix, respectively, using 1,000 genomes project reference populations. Within groups with ≥40% AA (AFR ≥0.4 ), and ≥15% NAA (AMR ≥0.15 ), genome‐wide association between local EA and glioma was evaluated using logistic regression conditioned on global EA for all gliomas. We identified two regions (7q21.11, p = 6.36 × 10 −4 ; 11p11.12, p = 7.0 × 10 −4 ) associated with increased EA, and one associated with decreased EA (20p12.13, p = 0.0026) in AFR ≥0.4 . In addition, we identified a peak at rs1620291 ( p = 4.36 × 10 −6 ) in 7q21.3. Among AMR ≥0.15 , we found an association between increased EA in one region (12q24.21, p = 8.38 × 10 −4 ), and decreased EA in two regions (8q24.21, p = 0. 0010; 20q13.33, p = 6.36 × 10 −4 ). No other significant associations were identified. This analysis identified an association between glioma and two regions previously identified in EA populations (8q24.21, 20q13.33) and four novel regions (7q21.11, 11p11.12, 12q24.21 and 20p12.13). The identifications of novel association with EA suggest regions to target for future genetic association studies.
Sinonasal Teratocarcinosarcoma: MRI and F18-FDG–PET/CT imaging
Nguyen, Ba D.

Mayo Clinic

Ear, Nose & Throat Journal | April 9, 2019 | Volume: 89 | Issue: 3 | Pages: 106-108

10.1177/014556131008900304 Get It

Sacrificial Bioprinting of a Mammary Ductal Carcinoma Model
Duchamp, Margaux , Liu, Tingting , Genderen, Anne Metje van , Kappings, Vanessa, Öklü, Rahmi , Ellisen, Leif W. , Oklu, Rahmi , Zhang, Yu Shrike

Mayo Clinic

Biotechnology Journal | April 9, 2019 | Volume: 14 | Issue: 10 | Pages: No page available

10.1002/biot.201700703 | PMID 30963705 Get It

Cancer tissue engineering has remained challenging due to the limitations of the conventional biofabrication techniques to model the complex tumor microenvironment. Here, the utilization of a sacrificial bioprinting strategy is reported to generate the biomimetic mammary duct‐like structure within a hydrogel matrix, which is further populated with breast cancer cells, to model the genesis of ductal carcinoma and its subsequent outward invasion. This bioprinted mammary ductal carcinoma model provides a proof‐of‐concept demonstration of the value of using the sacrificial bioprinting technique for engineering biologically relevant cancer models, which may be possibly extended to other cancer types where duct‐like structures are involved.
Oncocytoma Presenting as a Fat-Containing Intraparotid Mass
Anzalone, C. Lane , Nagelschneider, Alex A. , Sims, John R. , García, Joaquín J. , DeLone, David R. , Sims, John R., Price, Daniel L.

Mayo Clinic

Ear, Nose & Throat Journal | April 9, 2019 | Volume: 98 | Issue: 7 | Pages: 403-404

10.1177/0145561319841210 | PMID 30961383 Get It

Family Members’ Perceptions of Palliative Cancer Care: Predictors of Family Functioning and Family Members’ Health
Kristjanson, Linda J., Sloan, Jeff A. , Dudgeon, Deborah, Adaskin, Eleanor J.

Mayo Clinic

Journal of Palliative Care | April 9, 2019 | Volume: 12 | Issue: 4 | Pages: 10-20

10.1177/082585979601200403 Get It

We studied family members’ care experiences during the palliative care phase as predictors of family members’ health and family functioning during the palliative care phase and three months following the death of the patient. Eighty family members of advanced cancer patients participated in the study at time one (T1) (palliative care phase) and 64 family members completed the data collection protocol at time two (T2) (three months bereavement). Data were also obtained from 36 of the patients within one month of their deaths. Fulfillment theory accounted for 31% of the variance in family care satisfaction and Discrepancy theory accounted for 72% of the variance in family care satisfaction. Discrepancy theory predicted family functioning in the bereavement period (r=-0.33, p<0.05). Patients’ quality of life scores were moderately correlated with family members’ health during the palliative care phase (r=-0.38, p<0.05). Family members’ scores on the health index (symptom of stress scale) were significantly lower (p<0.05) than normative scores reported in a study using a healthy population. The strongest predictor of family members’ health scores in the bereavement period was their health score at T1 (r=0.71, p<0.01). As well, family functioning at T1 was strongly correlated with family functioning at T2.
White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities
Alber, Jessica , Alladi, Suvarna , Barton, David A., Bell, Joanne M., Berman, Sara E., Biessels, Geert Jan , Bos, Isabelle , Bowman, Gene L. , Brai, Emanuele , Callahan, Brandy L. , Corriveau, Roderick A. , Fossati, Silvia , Gottesman, Rebecca F. , Gustafson, Deborah , Hachinski, Vladimir , Hayden, Kathleen M. , Helman, Alex M., Hughes, Timothy M. , Isaacs, Jeremy D. , Jefferson, Angela L. , Kern, Silke , Kwon, Jay C., Lee, Athene , Lockhart, Samuel N. , Murray, Anne M. , Osborn, Katie E. , Price, Brittani R. , Rhodius‐Meester, Hanneke , Rondeau, Jacqueline A., Rosen, Allyson , Scholtzova, Henrieta , Shaaban, C. Elizabeth , Silva, Nárlon Cássio Boa Sorte , Snyder, Heather M. , Swardfager, Walter , Troen, Aron M. , Vemuri, Prashanthi , Wallin, Anders , Wellington, Cheryl L. , Xie, Sharon X. , Hainsworth, Atticus H. , Vemuri, Prashanthi , Gottesman, Rebecca F , Hainsworth, Atticus H , Bae, Hee‐Joon , Beckett, Laurel , Biessels, Geert Jan , Black, Sandra E. , Brickman, Adam M. , Johnson, Sterling C. , Kapasi, Alifiya , Kukolja, Juraj , Power, Melinda C. , Rosene, Douglas L , Schneider, Julie A. , Veluw, Susanne J. van , Wilcock, Donna M.

Mayo Clinic

Alzheimer's & Dementia: Translational Research & Clinical Interventions | April 8, 2019 | Volume: 5 | Issue: 1 | Pages: 107-117

10.1016/j.trci.2019.02.001 | PMID 31011621 Get It

Abstract White matter hyperintensities (WMHs) are frequently seen on brain magnetic resonance imaging scans of older people. Usually interpreted clinically as a surrogate for cerebral small vessel disease, WMHs are associated with increased likelihood of cognitive impairment and dementia (including Alzheimer's disease [AD]). WMHs are also seen in cognitively healthy people. In this collaboration of academic, clinical, and pharmaceutical industry perspectives, we identify outstanding questions about WMHs and their relation to cognition, dementia, and AD. What molecular and cellular changes underlie WMHs? What are the neuropathological correlates of WMHs? To what extent are demyelination and inflammation present? Is it helpful to subdivide into periventricular and subcortical WMHs? What do WMHs signify in people diagnosed with AD? What are the risk factors for developing WMHs? What preventive and therapeutic strategies target WMHs? Answering these questions will improve prevention and treatment of WMHs and dementia.
Parenteral Nutrition Drug Shortages: A Single‐Center Experience With Rapid Process Change
Nystrom, Erin M., Bergquist, Whitney J., Wieruszewski, Patrick M. , McMahon, M. Molly , Frazee, Erin N. , Frazee, Erin N , Wieruszewski, Patrick M

Mayo Clinic

Journal of Parenteral and Enteral Nutrition | April 8, 2019 | Volume: 43 | Issue: 5 | Pages: 583-590

10.1002/jpen.1538 | PMID 31531869 Get It

AbstractDisruptions in the medication supply chain and consequent drug product shortages, including shortages of parenteral products used for parenteral nutrition (PN) compounding, have become an increasingly common occurrence. The amino acid solution shortage that resulted from the devastating impact of Hurricanes Maria and Irma on manufacturing facilities in Puerto Rico in 2017 necessitated a rapid, coordinated shift from use of compounded PN to commercial multichamber‐bag PN (MCB‐PN) at our hospitals. We describe our experience operationalizing this intervention via a framework that may be adapted for addressing other drug product shortages to promote rapid yet safe use of therapeutic alternatives.
Ebolavirus polymerase uses an unconventional genome replication mechanism
Deflubé, Laure R., Cressey, Tessa, Hume, Adam J. , Olejnik, Judith , Haddock, Elaine , Feldmann, Friederike , Fearns, Rachel , Mühlberger, Elke , Mühlberger, Elke , Ebihara, Hideki

Mayo Clinic

Proceedings of the National Academy of Sciences | April 8, 2019 | Volume: 116 | Issue: 17 | Pages: 8535-8543

10.1073/pnas.1815745116 | PMID 30962389 Get It

Significance Ebolaviruses belong to the group of nonsegmented negative strand (NNS) RNA viruses. Most members of the Ebolavirus genus cause severe disease in humans. Here, we report that ebolaviruses have evolved a genome replication mechanism that distinguishes them from the other NNS RNA viruses. The ebolavirus replication strategy includes the addition of a nontemplated 3′ nucleotide at the genome ends which may aid in avoiding antiviral recognition. Our data highlight the need for more research on NNS RNA virus replication strategies to reveal commonalities between virus families as well as unique features. Dissecting the replication mechanisms of NNS RNA viruses, including ebolaviruses, paves the way for the development of broad-spectrum antivirals that target the viral replication complexes, thereby preventing virus amplification.